Press Releases Alcon Inc.

Equities

ALC

CH0432492467

Real-time Estimate Cboe Europe Other stock markets 06:36:36 2024-05-08 am EDT			5-day change	1st Jan Change
73.44 ^CHF	+0.16%		+3.12%	+11.85%

Apr. 29	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT
Apr. 29	Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alcon Publishes Agenda for 2024 Annual General Meeting	Apr. 07	BU
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Apr. 01	AQ
Alcon : Terry Kim, MD, Joins Alcon as Chief Medical Officer and Head of Global Medical Safety	Mar. 26	PU
Alcon : Terry Kim, MD, Joins Alcon as Chief Medical Officer and Head of Global Medical Safety	Mar. 26	PU
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India	Mar. 12	BU
Alcon - Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone	Mar. 07	AQ
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone	Mar. 06	BU
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone	Mar. 06	BU
Alcon Loses Sight Of Dismissal In Suit Over Its Eye Drops' "30 Day Supply" Claims	Mar. 04	AQ
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023	Feb. 27	BU
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye	Jan. 09	BU
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference	Dec. 27	BU
Alcon Reports Third Quarter 2023 Results	Nov. 14	BU
Alcon : Third Quarter 2023 Earnings Conference Call Regulatory Filing	Nov. 13	PU
Alcon : Third Quarter 2023 Earnings Conference Call Press Release	Nov. 13	PU
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023	23-10-30	BU
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia	23-10-10	BU
Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence	23-09-09	BU
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams	23-09-06	BU
Alcon Reports Second Quarter 2023 Results	23-08-15	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ALCON : Despite the slight Q4 miss, the markets cheered the 2024 guidance

February 28, 2024 at 07:44 am EST

ALCON : Optimum visibility for the future

May 29, 2023 at 06:08 am EDT